Treatment Of Acute Myeloid Leukemia Hanging On Life ~ Acute myeloid leukemia is a heterogeneous cancer of the blood and bone marrow. This volume is displayed as a result of overproduction of immature white blood cell called myeloblasts.
The name of the disease is obtained from the blood cells in excess. The immature white blood cells in the bone marrow generates and give to the output prevents the production of normal blood cells.
Because immature and mature blood and reduce proper operation, the operation is greatly reduced as blood cells. An affected blood functions in acute myeloid leukemia is fighting infection.
Patients with acute myeloid leukemia easily contaminated by reduced immunity to infection. Suffer Another very common symptom in patients with acute myelogenous leukemia, is anemia. Anemia is reduced as a result of production of normal red blood cells and platelets. acute myeloid leukemia have hurt others as easily have symptoms and swollen gums, nose bleeding, fever, pale skin, and even respiratory distress.
Treatment of acute myelogenous leukemia in newly diagnosed patients receiving chemotherapy (the type of chemotherapy used depends on age) to induce rapid complete remission, if reached, the subsequent treatment is then directed, the disease cure (eliminates any waste no leukemic cells detected). The first phase is the induction phase. 200 mg / m2 / day during a week - the cytarabine is administered intravenously at 100th The anthracycline daunorubicin consisting administered intravenously 45-60mg / m2 on days 1, 2 and 3. If the induction treatment is completed, the bone marrow is examined. If the stem cells to 20% of more than 5% of mobile cells, the induction treatment and again the first carried out with a similar dose, but the cytarabine is administered 5 and anthracycline for 2 days. The second step is to delete or consolidation therapy in treating patients with acute myelogenous leukemia depends on leukemic cells are not detectable. In this treatment, the treatment by the patient, the treatment includes a further intensive chemotherapy courses 3 to 5 patients with high-risk cytogenetics is allogeneic stem given. Patients with stem cell transplantation is not suitably treated with a combination therapy histamine dihydrochloride (Ceplene) and interleukin-2.
Treatment of acute myeloid leukemia in the past show good prognosis, especially if the diagnosis is made the ant treatment early start immediately.